An intelligent modular approach that delivers significantly more efficient and effective ways of managing content across the Clinical, Labeling, Regulatory, Medical, and Commercial supply chain. Intelligent Content extensively combines AI and advanced analytics along with deep domain expertise to transform experiences around how pharmaceutical content is created, discovered, measured, personalized, and published in new-age interfaces.
The pharmaceutical industry deals with terabytes of content and huge volumes of related documents on a day-to-day basis. Content regulations across markets further complicate the process. Bespoke legacy applications to manage this content result in information silos, inefficient human-dependent processes, long content cycles, high costs of compliance, and longer times to market. Indegene’s Intelligent Content approach resolves these challenges by enabling pharmaceutical organizations to get on an accelerated path of digital transformation, empowering them to create, curate, and manage all content in a centralized manner, automate content life cycles, and optimize processes while ensuring regulatory compliance and faster time to market.
Faster Time to Market
Consistent Content Quality
Improved Customer Engagement and Marketing ROI
Reduced Costs of Compliance
Centralize all existing and new labeling documents onto a single platform and convert them into structured reusable components that can intuitively flow across upstream and downstream labels. Leverage capabilities like assisted label authoring, content lineage, proactive deviation tracking and harmonization, cognitive content search, and regulatory submission planning to achieve end-to-end labeling content management using a single platform.Know more
Sian Ratcliffe, Head of Medical Writing, from Pfizer and Tarun Mathur, Chief Technology Officer, from Indegene discuss how, at Pfizer, content generated throughout the drug development lifecycle is managed using medically trained machine intelligence to accelerate authoring and updating of clinical and regulatory documents.